These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26664162)

  • 1. Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease.
    Sharifi H; Masjedi MR; Emami H; Ghanei M; Eslaminejad A; Radmand G; Buist S
    Lung India; 2015; 32(6):572-7. PubMed ID: 26664162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of obstructive lung disease study in Iran: First report of the prevalence and risk factors of copd in five provinces.
    Sharifi H; Ghanei M; Jamaati H; Masjedi MR; Aarabi M; Sharifpour A; Radmand G; Buist AS
    Lung India; 2019; 36(1):14-19. PubMed ID: 30604700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim Report from Burden of Obstructive Lung Disease (BOLD Study) in Tehran: Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease.
    Sharifi H; Masjedi MR; Emami H; Ghanei M; Eslaminejad A; Radmand G; Buist AS
    Tanaffos; 2014; 13(3):6-13. PubMed ID: 25713586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.
    Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P
    Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Obstructive Lung Disease in Iran: Prevalence and Risk Factors for COPD in North of Iran.
    Sharifi H; Ghanei M; Jamaati H; Masjedi MR; Aarabi M; Sharifpour A; Radmand G; Najafimehr H; Buist AS
    Int J Prev Med; 2020; 11():78. PubMed ID: 33033587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of obstructive lung disease study in tehran: research design and lung spirometry protocol.
    Sharifi H; Masjedi MR; Emami H; Ghanei M; Buist S
    Int J Prev Med; 2014 Nov; 5(11):1439-45. PubMed ID: 25538840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.
    Tupper OD; Kjeldgaard P; Løkke A; Ulrik CS
    Chron Respir Dis; 2018 Nov; 15(4):393-399. PubMed ID: 29486583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
    Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
    Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: An observational survey.
    Nguyen Viet N; Yunus F; Nguyen Thi Phuong A; Dao Bich V; Damayanti T; Wiyono WH; Billot L; Jakes RW; Kwon N
    Respirology; 2015 May; 20(4):602-11. PubMed ID: 25781616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
    Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analyses of the rate of spirometry examination and its related factors in chronic obstructive pulmonary diseasepatients aged 40 years or older in China, 2014-2015].
    Lyu XL; Cong S; Fan J; Zhang Y; Wang N; Bao HL; Wang BH; Wang Q; Wang LH; Fang LW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):672-677. PubMed ID: 32447905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.